TAVR sales were up 9% for Edwards in Street-beating Q2

Edwards Lifesciences (NYSE: EW) shares fell after hours today despite second-quarter results that beat the consensus forecast.

Related Keywords

Irvine ,California ,United States ,Massdevice Medtech ,Bernard Zovighian , ,Edwards Lifesciences ,Wall Street ,Pascal Precision ,